- Home
- APLT vs GLU Comparison
APLT vs GLU Comparison
Compare APLT & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- GLU
- Stock Information
- Founded
- APLT 2016
- GLU 2004
- Country
- APLT United States
- GLU United States
- Employees
- APLT N/A
- GLU N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- GLU Finance/Investors Services
- Sector
- APLT Health Care
- GLU Finance
- Exchange
- APLT Nasdaq
- GLU Nasdaq
- Market Cap
- APLT 80.3M
- GLU 92.2M
- IPO Year
- APLT 2019
- GLU N/A
- Fundamental
- Price
- APLT $0.53
- GLU $16.05
- Analyst Decision
- APLT Buy
- GLU
- Analyst Count
- APLT 7
- GLU 0
- Target Price
- APLT $6.10
- GLU N/A
- AVG Volume (30 Days)
- APLT 3.0M
- GLU 12.4K
- Earning Date
- APLT 03-05-2025
- GLU 01-01-0001
- Dividend Yield
- APLT N/A
- GLU 8.60%
- EPS Growth
- APLT N/A
- GLU N/A
- EPS
- APLT N/A
- GLU 0.62
- Revenue
- APLT N/A
- GLU N/A
- Revenue This Year
- APLT N/A
- GLU N/A
- Revenue Next Year
- APLT $2,622.90
- GLU N/A
- P/E Ratio
- APLT N/A
- GLU $22.50
- Revenue Growth
- APLT N/A
- GLU N/A
- 52 Week Low
- APLT $0.53
- GLU $11.61
- 52 Week High
- APLT $10.62
- GLU $15.40
- Technical
- Relative Strength Index (RSI)
- APLT 29.75
- GLU 60.55
- Support Level
- APLT $0.54
- GLU $15.64
- Resistance Level
- APLT $0.70
- GLU $16.28
- Average True Range (ATR)
- APLT 0.06
- GLU 0.33
- MACD
- APLT 0.06
- GLU 0.07
- Stochastic Oscillator
- APLT 0.00
- GLU 77.23
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.